Varian, Inc.
Palo Alto, CA 94304
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »
Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center
Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management...
Read More »
Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center
Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management...
Read More »
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment room...
Read More »
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment room...
Read More »
New Proton Therapy System Offers Clinical Capabilities with up to 30% Small Footprint
ProBeam 360° system allows cancer centers to tailor the system to meet their clinical, research, and capacity needs. Treatment room options include 360-degree rotating gantries, and fixed beam rooms. Provide clinicians a viable path to potential next-generation treatments such as FLASH therapy.
Read More »
New Proton Therapy System Offers Clinical Capabilities with up to 30% Small Footprint
ProBeam 360° system allows cancer centers to tailor the system to meet their clinical, research, and capacity needs. Treatment room options include 360-degree rotating gantries, and fixed beam rooms. Provide clinicians a viable path to potential next-generation treatments such as FLASH therapy.
Read More »
New Ethos Therapy Provides Fast Imaging and Treatment Delivery
Offers the use of multimodality images (MR, PET, CT) and daily iterative CBCT images at the console. Ability to alter the treatment plan based on tumor and anatomical changes. Enable users to visualize the changes in patient's anatomy and adapts the therapy accordingly to help provide treatments to patients.
Read More »
New Ethos Therapy Provides Fast Imaging and Treatment Delivery
Offers the use of multimodality images (MR, PET, CT) and daily iterative CBCT images at the console. Ability to alter the treatment plan based on tumor and anatomical changes. Enable users to visualize the changes in patient's anatomy and adapts the therapy accordingly to help provide treatments to patients.
Read More »Varian Establishes Direct Operation in Kenya
PALO ALTO, California and NAIROBI, Kenya, Nov. 26, 2019 /PRNewswire/ -- At a grand opening ceremony attended by local dignitaries (H.E. Governor Prof. Anyan'g Nyong'o – Governor of Kisumu County, Vice Chairman – CoG Health Committee; Hon. Dr. Swarup Mishra Kiprop Arap Chelulei – MP – Kesses, Group Chairman, Founder Mediheal Hospitals, Vice Chairman - Parliament Health Committee;...
Read More »Varian Establishes Direct Operation in Kenya
PALO ALTO, California and NAIROBI, Kenya, Nov. 26, 2019 /PRNewswire/ -- At a grand opening ceremony attended by local dignitaries (H.E. Governor Prof. Anyan'g Nyong'o – Governor of Kisumu County, Vice Chairman – CoG Health Committee; Hon. Dr. Swarup Mishra Kiprop Arap Chelulei – MP – Kesses, Group Chairman, Founder Mediheal Hospitals, Vice Chairman - Parliament Health Committee;...
Read More »
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
Palo Alto, Calif., Nov. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian was ranked number three in the Healthcare Equipment and Services Industry and number 39 on this year's overall list for outperforming its peers in...
Read More »Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
Palo Alto, Calif., Nov. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian was ranked number three in the Healthcare Equipment and Services Industry and number 39 on this year's overall list for outperforming its peers in...
Read More »Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Ca
PALO ALTO, Calif., Nov. 6, 2019 /PRNewswire/ -- In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support its efforts to develop patient-centered quality measures for cancer care. This year, there were an estimated 58,000 new cancer cases in the state of...
Read More »Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Ca
PALO ALTO, Calif., Nov. 6, 2019 /PRNewswire/ -- In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support its efforts to develop patient-centered quality measures for cancer care. This year, there were an estimated 58,000 new cancer cases in the state of...
Read More »Varian Names Anshul Maheshwari Vice President Investor Relations
Palo Alto, Calif., Oct. 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries should be directed to Mr. Maheshwari. Prior to joining Varian in July 2018, Mr. Maheshwari was the assistant treasurer of Bechtel Corporation, where he had...
Read More »Varian Names Anshul Maheshwari Vice President Investor Relations
Palo Alto, Calif., Oct. 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries should be directed to Mr. Maheshwari. Prior to joining Varian in July 2018, Mr. Maheshwari was the assistant treasurer of Bechtel Corporation, where he had...
Read More »